Nalbuphine in ARDS Patients After Surgery
NCT06037330
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Acute Respiratory Distress Syndrome
Interventions
DRUG:
Nalbuphine
DRUG:
Sufentanil
Sponsor
Hairong Chen